RCEL - Avita Medical Limited

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
9.90
-0.35 (-3.41%)
At close: 4:00PM EST
Stock chart is not supported by your current browser
Previous Close10.25
Open10.17
Bid9.80 x 800
Ask10.34 x 1400
Day's Range9.90 - 10.20
52 Week Range1.87 - 11.07
Volume455,054
Avg. Volume486,831
Market Cap1.072B
Beta (5Y Monthly)1.11
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est12.00
  • Business Wire

    AVITA Medical Half-Year Financial Report for Fiscal 2020

    AVITA Medical Limited (ASX: AVH, NASDAQ: RCEL), a regenerative medicine company with a technology platform positioned to address unmet medical needs in therapeutic skin restoration, announced that it filed today with the Australian Securities Exchange (ASX) its Appendix 4D – Half-Year Report for the six month period ended 31 December 2019.

  • Business Wire

    AVITA Medical to Present at the Cowen 40th Annual Health Care Conference

    AVITA Medical (ASX: AVH) (NASDAQ: RCEL), a global regenerative medicine company, announced that management will present at the Cowen 40th Annual Health Care Conference in Boston. The presentation is being made on 4 March 2020 from 9:20 a.m. to 9:50 a.m. EST at the Boston Marriott Copley Place hotel. Interested parties may access a webcast of the presentation on the "Investors" section of the company’s website at: https://www.avitamedical.com/investors.

  • Did The Underlying Business Drive Avita Medical's (ASX:AVH) Lovely 730% Share Price Gain?
    Simply Wall St.

    Did The Underlying Business Drive Avita Medical's (ASX:AVH) Lovely 730% Share Price Gain?

    We think all investors should try to buy and hold high quality multi-year winners. And we've seen some truly amazing...

  • Business Wire

    AVITA Medical Reports Second Quarter Fiscal 2020 Financial Results and Company Update

    AVITA Medical Limited (ASX: AVH, NASDAQ: RCEL), a regenerative medicine company with a technology platform positioned to address unmet medical needs in therapeutic skin restoration, reported financial results for the fiscal second quarter ended 31 December 2019 today in its Appendix 4C - Quarterly Cash Flow Report filed with the Australian Securities Exchange (ASX).

  • Our Take On Avita Medical Limited's (ASX:AVH) CEO Salary
    Simply Wall St.

    Our Take On Avita Medical Limited's (ASX:AVH) CEO Salary

    Mike Perry has been the CEO of Avita Medical Limited (ASX:AVH) since 2017. First, this article will compare CEO...

  • Benzinga

    PreMarket Prep Recap: 'Mad Money' Follies And Buffett Hits Another Home Run

    After-hours price action in Avita Medical Ltd. ADR (NASDAQ: RCEL ), a blockbuster earnings report and a significant ratings change were a few of the topics on today's PreMarket Prep Show . Buyer Beware ...

  • Avita Medical Could Double in 2020 but Not Without Risk
    TheStreet.com

    Avita Medical Could Double in 2020 but Not Without Risk

    In his second "Executive Decision" segment of Mad Money Wednesday night, Jim Cramer sat down with Dr. Mike Perry, CEO of Avita Medical , a company pioneering new treatments for burn and wound care. Avita's treatment uses significantly less donor skin to create a spray that can be applied to wide areas of the body. Not only is Avita's treatment less painful, Perry said, it's also less costly and provides a better outcome aesthetically.

  • How Avita Medical Limited (ASX:AVH) Can Impact Your Portfolio Volatility
    Simply Wall St.

    How Avita Medical Limited (ASX:AVH) Can Impact Your Portfolio Volatility

    If you're interested in Avita Medical Limited (ASX:AVH), then you might want to consider its beta (a measure of share...